All Episodes

Ticagrelor versus Clopidogrel in Endovascular therapy for Cerebral Aneurysms: A Systematic Review and Meta-analysis

Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry

One year clinical outcome of dual anti-platelet therapy with the Novel Ticagrelor plus Aspirin versus Clopidogrel plus Aspirin for Endovascular Intervention of patients with Intracranial Aneurysm

The Prognostic impact of treatments evolution in STEMI

Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): a systematic review and meta-analysis

Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction

De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in East Asian Patients With Acute Coronary Syndrome

Effect of beta-blockers and exercise restriction on the prevention of sudden cardiac death in pediatric hypertrophic cardiomyopathy

Emergent use of ticagrelor during endovascular reperfusion in large arterial occlusions

ARTESIA Study Indicates Apixaban Reduces Stroke Risk but Increases Bleeding in Subclinical AF

CARDIA-SSBP Study Reveals 6 mm Hg Blood Pressure Reduction in One Week with Low- Salt Diet

Bleeding Reduction in LVAD Patients with Aspirin Discontinuation: ARIES-HM3 Trial

Liberal Transfusion in Anemic MI Cases Shows Favorable Results: MINT Study

Effectiveness and Safety of P2Y12 Inhibitor Pretreatment for Primary PCI in STEMI: Systematic Review and Meta-analysis

Sex and Age Differences of Major Cardiovascular Events in Patients After Percutaneous Coronary Intervention

Comparison of Ticagrelor Monotherapy and Ticagrelor Plus Aspirin Among Patients With Acute Coronary Syndrome Combined With High-Risk of Gastrointestinal Bleeding After PCI

β1-blockers in the reduction of bleeding risk in patients prescribed with potent dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction

Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Factors associated with complications in ST-elevation myocardial infarction: a single-center experience

Effect of ticagrelor and clopidogrel dual antiplatelet therapy on MPVLR, MAADP, and AA inhibition rate in acute coronary syndrome patients after percutaneous coronary intervention

Prognostic factors in young patients with ST-segment elevation myocardial infarction

Early Effects of Ticagrelor Versus Clopidogrel on Peripheral Endothelial Function After Non-ST-Elevation Acute Coronary Syndrome and Assessment of Its Relationship With Coronary Microvascular Function

Comparative Effectiveness of Long-Term Maintenance Beta-Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention

Metoprolol or Verapamil in the Management of Patients With Hypertrophic Cardiomyopathy: A Systematic Review

2023 ESH Guideline for the Management of Hypertension with specific focus on Beta blockers

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

Impact of Diabetes Mellitus on Benefit of β-Blocker Therapy After Myocardial Infarction

Clinical risk factors and outcomes of young patients with acute ST segment elevation myocardial infarction: a retrospective study

Frequency of New Onset Atrial Fibrillation in Patients Presenting with ST-Segment Elevation Myocardial Infarction

The prognostic value of myocardial salvage index by cardiac magnetic resonance in ST-segment elevation myocardial infarction patients: a systematic review and meta-analysis.

Association between the beta-blockers, calcium channel blockers, all-cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction.

Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial

Impact of Diabetes Mellitus on Benefit of β-Blocker Therapy After Myocardial Infarction

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction

Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction

Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials

Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction without Heart Failure Undergoing Primary P

Safe and Effective Early Use of Betablockers after Pediatric Heart Transplantation

Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction

Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction

Sex-related bleeding risk in acute coronary syndrome patients receiving dual antiplatelet therapy with aspirin and a P2Y12 inhibitor

Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials

Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials

Can platelet count be controlled with ticagrelor in patients with essential thrombocythaemia? A case series

Interventional therapy of acute coronary syndromes in very old patient population and results of 2 years follow-up

Blood pressure lowering effects of β-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials

A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome

Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial

Stroke Recurrence and Antiplatelets in Posterior Versus Anterior Circulation Minor Stroke or Transient Ischemic Attack

Association between the number of academic research consortium for high bleeding risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome

Role of β-blockers in Preventing Heart Failure and Major Adverse Cardiac Events Post Myocardial Infarction

Baroreflex sensitivity predicts therapeutic effects of metoprolol on pediatric postural orthostatic tachycardia syndrome

Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease

The prognostic effect of ST-elevation in lead aVR on coronary artery disease, and outcome in acute coronary syndrome patients: a systematic review and meta-analysis

Cardio-selective versus non-selective β-blockers for cardiovascular events and mortality in long-term dialysis patients: A systematic review and meta-analysis

Efficacy of metoprolol plus atorvastatin for carotid atherosclerosis and its influence on carotid intima-media thickness and homocysteine level

Treatment of the New Era: Long-Term Ticagrelor Monotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus following Percutaneous Coronary Intervention: A Meta-analysis

Associations of systemic inflammation and social support with suicidal ideation in patients with acute coronary syndrome and stroke

Comparison of Rate Control Efficacy between beta-blockers and Calcium Channel Blockers in Patients Hospitalized with Atrial Fibrillation

Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart

A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke

Efficacy and Safety of Sustained-Release Metoprolol with Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis

Incidence and predictors of heart failure after acute coronary Syndrome: The CORALYS registry

Effect of β-Blocker Therapy on the Level of Soluble ST2 Protein in Pediatric Dilated Cardiomyopathy

Clopidogrel resistance and ticagrelor replacement in dual antiplatelet therapy for carotid artery stenting

Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials

Safety and efficacy of dual antiplatelet therapy combining aspirin and ticagrelor in patients with undergoing intracranial stenting procedures

Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy

Ticagrelor versus clopidogrel in reducing inflammatory cell infiltration of thrombus aspirated in patients with ST-elevation myocardial infarction

Beta-blockers in acute coronary syndrome: does rhythm matter?

Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

Bleeding outcomes with ticagrelor versus clopidogrel in patients with the acute coronary syndrome; a focused analysis from the multicenter CREA ARIAM Andalucia registry

Conservative management in a contemporary cohort of patients with acute coronary syndrome: Results from the FORCE-ACS registryConservative management in a contemporary cohort of patients with acute co

Coronary Artery Embolism and Acute Coronary Syndrome: A critical appraisal of existing data Trends

Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy

Beta-blocker Use After Thoracic Endovascular Aortic Repair in Patients with Type B Aortic Dissection Is Associated with Improved Early Aortic Remodeling

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis

Management of acute coronary syndrome without ST-segment elevation

The impact of a comprehensive pharmaceutical care intervention in addition to cardiac rehabilitation program on outcomes of post-acute coronary syndrome patients: A pilot study

Effects of Metoprolol Succinate Combined with Entresto on Cardiac Function Indexes and Coagulation Function in Patients with Congestive Heart Failure

Comparative Safety and Effectiveness of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Analysis from a Multicentre Registry

Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement

Efficacy and Safety of Ticagrelor Over Time in Patients with Prior MI in PEGASUS-TIMI 54

Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

Timing of Oral P2Y12 Inhibitor Administration in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome

Effect of Ticagrelor Monotherapy vs Ticagrelor with Aspirin on Major Bleeding and Cardiovascular Events in Patients with Acute Coronary Syndrome: The TICO Randomized Clinical Trial

Low-Dose Triple Combination Antihypertensive Therapy vs Usual Care and Time at Target Blood Pressure

Initial Decline in eGFR After Dapagliflozin Initiation and Its Associated Outcomes in Patients with HFrEF

Elevated Lipoprotein(a) and Risk of Atrial Fibrillation

DAPT Discontinuation, Platelet Reactivity, and Adverse Outcomes After PCi

Oral Anticoagulant treatment and the risk of dementia in patients with atrial fibrillation.

The AMPLITUDE-O Trial : CVOT of Efpeglenatide, a new potent, exendin-4-based weekly subcutaneous GLP-1 receptor agonist

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary

Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review

Tight control of blood pressure in pregnant women with non-severe hypertension: expectations for decreasing adverse maternal and fatal pregnancy outcomes

Effect of Chloride levels in HF therapy

Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes

Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation